Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 1,508 shares at $6.42 ($10K) on 2017-02-16, disclosed to the SEC on 2017-02-17.
Seasonal sale ($10k) by Chief Operating Officer — this insider has traded STML in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |